Update on the COVID-19 pandemic

Information regarding COVID-19 is in constant change, as is the situation regarding vaccination and prioritization for immune-compromised individuals.

If you have any COVID-19-related questions, we’ve created a specific COVID section on our website that can be accessed by clicking here or by selecting the “News & Events” tab from our homepage. In this section, you’ll find the latest news and information about the pandemic in Canada from trustworthy and reliable sources.

Any specific questions that you may have regarding the COVID-19 vaccination, delays between vaccine dosing, and prioritization within your province are best answered by your healthcare team. They’re the ones who know you and your particular situation and are therefore in a position to best address your unique concerns.

Created by, and entirely focused on, Canadians impacted by myeloma, Myeloma Canada is the only national charitable organization committed to providing you with the most up-to-date and reliable information on myeloma. Some of the ways we do this is through our monthly e-newsletter, “Myeloma Matters”, as well as through our social media platforms.

Please don’t hesitate to contact us at contact@myeloma.ca or toll-free at 1-888-798-5771 with any questions regarding our programs and services.

Close

Make a donation

Canadian Myeloma Research Group (CMRG)

Bringing More Clinical Trials, to More Patients, in More Centres Across Canada

In Canada, researchers figure prominently in the development of innovative and very promising clinical trials. The Canadian Myeloma Research Group (CMRG), formerly Myeloma Canada Research Network (MCRN), is the first and only national organization bringing together Canada’s leading cancer institutions and researchers to collaborate in advancing myeloma research. The CMRG platform facilitates advancement of research in myeloma by providing infrastructure and expertise in three core areas: 

  • Clinical trial development and management
  • Real-world evidence generation and research through the CMRG National Myeloma Database
  • Support of basic and translational research through its national Myeloma Bio Bank initiative 

CMRG also develops national treatment and consensus guidelines to improve patient care and outcomes.

Incorporating patient input in research design is a priority for CMRG and Myeloma Canada supports CMRG’s patient-centric approach to research.

This past year the CMRG conducted several clinical trials that benefited patients across the country.

Visit the CMRG Website